Integrated omic analysis of oropharyngeal carcinomas reveals human papillomavirus (HPV) - Dependent regulation of the activator protein 1 (AP-1) pathway

Molecular and Cellular Proteomics

Volumn 13, Issue 12, 2014, Pages 3572-3584

  Sepiashvili, Lusia ^a,b   Waggott, Daryl ^c   Hui, Angela ^b   Shi, Wei ^b   Su, Susie ^d   Ignatchenko, Alex ^b   Ignatchenko, Vladimir ^b   Laureano, Marissa ^b   Huang, Shao Hui ^a   Xu, Wei ^d   Weinreb, Ilan ^a   Waldron, John ^a   O'Sullivan, Brian ^a   Irish, Jonathan C ^a   Boutros, Paul C ^a,c,d   Liu, Fei Fei ^a,b   Kislinger, Thomas ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

5' METHYLTHIOADENOSINE PHOSPHORYLASE; ANTINEOPLASTIC AGENT; BETA1 INTEGRIN; CORTACTIN; DNA; FOCAL ADHESION KINASE; FORMALDEHYDE; MESSENGER RNA; ONCOPROTEIN; PARAFFIN; PROTEIN; STRESS ACTIVATED PROTEIN KINASE 1; TRANSCRIPTION FACTOR AP 1; 5'-METHYLTHIOADENOSINE PHOSPHORYLASE; CTTN PROTEIN, HUMAN; FOCAL ADHESION KINASE 1; PTK2 PROTEIN, HUMAN; PURINE NUCLEOSIDE PHOSPHORYLASE;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER PATIENT; CELL CYCLE; CHEMORADIOTHERAPY; COHORT ANALYSIS; CONTROLLED STUDY; COPY NUMBER VARIATION; CORRELATIONAL STUDY; DNA REPLICATION; FEMALE; GENE MUTATION; GENE TARGETING; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OROPHARYNX CARCINOMA; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN METHYLATION; PROTEOMICS; RADIOSENSITIVITY; RISK REDUCTION; SIGNAL TRANSDUCTION; SURVIVAL RATE; TISSUE SECTION; TRANSCRIPTION REGULATION; WART VIRUS; CARCINOMA; COMPLICATION; GENE EXPRESSION REGULATION; GENETICS; HOST PATHOGEN INTERACTION; INNATE IMMUNITY; METABOLISM; MIDDLE AGED; MORTALITY; OROPHARYNX TUMOR; PAPILLOMAVIRIDAE; PATHOLOGY; PHYSIOLOGY; SURVIVAL; VERY ELDERLY;

HUMAN PAPILLOMAVIRUS;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD29; APOPTOSIS; CARCINOMA; CELL CYCLE; COHORT STUDIES; CORTACTIN; DNA REPLICATION; FEMALE; FOCAL ADHESION KINASE 1; GENE EXPRESSION REGULATION, NEOPLASTIC; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; MALE; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASE 8; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PURINE-NUCLEOSIDE PHOSPHORYLASE; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS; TRANSCRIPTION FACTOR AP-1;

EID: 84922158627     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M114.041764     Document Type: Article

References (52)

1. Chaturvedi, A. K., Engels, E. A., Anderson, W. F., and Gillison, M. L. (2008) Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J. Clin. Oncol. 26, 612-619
2. Habbous, S., Chu, K. P., Qiu, X., La Delfa, A., Harland, L. T., Fadhel, E., Hui, A., Perez-Ordonez, B., Weinreb, I., Liu, F. F., Waldron, J., O'Sullivan, B., Goldstein, D., Xu, W., Huang, S. H., and Liu, G. (2013) The changing incidence of human papillomavirus-associated oropharyngeal cancer using multiple imputation from 2000 to 2010 at a Comprehensive Cancer Centre. Cancer Epidemiol. 37, 820-829
3. Leemans, C. R., Braakhuis, B. J., and Brakenhoff, R. H. (2011) The molecular biology of head and neck cancer. Nat. Rev. Cancer 11, 9-22
4. O'Sullivan, B., Huang, S. H., Siu, L. L., Waldron, J., Zhao, H., Perez-Ordonez, B., Weinreb, I., Kim, J., Ringash, J., Bayley, A., Dawson, L. A., Hope, A., Cho, J., Irish, J., Gilbert, R., Gullane, P., Hui, A., Liu, F. F., Chen, E., and Xu, W. (2013) Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis. J. Clin. Oncol. 31, 543-550
5. Shi, W., Kato, H., Perez-Ordonez, B., Pintilie, M., Huang, S., Hui, A., O'Sullivan, B., Waldron, J., Cummings, B., Kim, J., Ringash, J., Dawson, L. A., Gullane, P., Siu, L., Gillison, M., and Liu, F. F. (2009) Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma. J. Clin. Oncol. 27, 6213-6221
6. zur Hausen, H. (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2, 342-350
7. El-Naggar, A. K., and Westra, W. H. (2012) p16 expression as a surrogate marker for HPV-related oropharyngeal carcinoma: a guide for interpretative relevance and consistency. Head Neck 34, 459-461
8. Slebos, R. J., Yi, Y., Ely, K., Carter, J., Evjen, A., Zhang, X., Shyr, Y., Murphy, B. M., Cmelak, A. J., Burkey, B. B., Netterville, J. L., Levy, S., Yarbrough, W. G., and Chung, C. H. (2006) Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma. Clin. Cancer Res. 12, 701-709
9. Gillison, M. L., Koch, W. M., Capone, R. B., Spafford, M., Westra, W. H., Wu, L., Zahurak, M. L., Daniel, R. W., Viglione, M., Symer, D. E., Shah, K. V., and Sidransky, D. (2000) Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J. Natl. Cancer Inst. 92, 709-720
10. Braakhuis, B. J., Snijders, P. J., Keune, W. J., Meijer, C. J., Ruijter-Schippers, H. J., Leemans, C. R., and Brakenhoff, R. H. (2004) Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. J. Natl. Cancer Inst. 96, 998-1006
11. Lui, V. W., and Grandis, J. R. (2012) Primary chemotherapy and radiation as a treatment strategy for HPV-positive oropharyngeal cancer. Head Neck Pathol. 6 Suppl 1, S91-S97
12. Magdeldin, S., and Yamamoto, T. (2012) Toward deciphering proteomes of formalin-fixed paraffin-embedded (FFPE) tissues. Proteomics 12, 1045-1058
13. Ralton, L. D., and Murray, G. I. (2011) The use of formalin fixed wax embedded tissue for proteomic analysis. J. Clin. Pathol. 64, 297-302
14. Patel, V., Hood, B. L., Molinolo, A. A., Lee, N. H., Conrads, T. P., Braisted, J. C., Krizman, D. B., Veenstra, T. D., and Gutkind, J. S. (2008) Proteomic analysis of laser-captured paraffin-embedded tissues: a molecular portrait of head and neck cancer progression. Clin. Cancer Res. 14, 1002-1014
15. Naidoo, K., Jones, R., Dmitrovic, B., Wijesuriya, N., Kocher, H., Hart, I. R., and Crnogorac-Jurcevic, T. (2012) Proteome of formalin-fixed paraffin-embedded pancreatic ductal adenocarcinoma and lymph node metastases. J. Pathol. 226, 756-763
16. Wisniewski, J. R., Ostasiewicz, P., Dus, K., Zielinska, D. F., Gnad, F., and Mann, M. (2012) Extensive quantitative remodeling of the proteome between normal colon tissue and adenocarcinoma. Mol. Syst. Biol. 8, 611
17. Ellis, M. J., Gillette, M., Carr, S. A., Paulovich, A. G., Smith, R. D., Rodland, K. K., Townsend, R. R., Kinsinger, C., Mesri, M., Rodriguez, H., and Liebler, D. C. (2013) Connecting genomic alterations to cancer biology with proteomics: the NCI Clinical Proteomic Tumor Analysis Consortium. Cancer Discov. 3, 1108-1112
18. Crick, F. (1970) Central dogma of molecular biology. Nature 227, 561-563
19. Zhang, B., Wang, J., Wang, X., Zhu, J., Liu, Q., Shi, Z., Chambers, M. C., Zimmerman, L. J., Shaddox, K. F., Kim, S., Davies, S. R., Wang, S., Wang, P., Kinsinger, C. R., Rivers, R. C., Rodriguez, H., Townsend, R. R., Ellis, M. J., Carr, S. A., Tabb, D. L., Coffey, R. J., Slebos, R. J., Liebler, D. C., and National Cancer Institute Clinical Proteomics Tumor Analysis Consortium (2014) Proteogenomic characterization of human colon and rectal cancer. Nature 513, 382-387
20. Alfaro, A. A., Sinha, A., Kislinger, T., and Boutros, P. C. (2014) Oncoproteogenomics: cancer proteomics joins forces with genomics. Nat. Methods, 11, 1107-1113
21. Sepiashvili, L., Hui, A., Ignatchenko, V., Shi, W., Su, S., Xu, W., Huang, S. H., O'Sullivan, B., Waldron, J., Irish, J. C., Perez-Ordonez, B., Liu, F. F., and Kislinger, T. (2012) Potentially novel candidate biomarkers for head and neck squamous cell carcinoma identified using an integrated cell line-based discovery strategy. Mol. Cell. Proteomics 11, 1404-1415
22. Taylor, P., Nielsen, P. A., Trelle, M. B., Horning, O. B., Andersen, M. B., Vorm, O., Moran, M. F., and Kislinger, T. (2009) Automated 2D peptide separation on a 1D nano-LC-MS system. J. Proteome Res. 8, 1610-1616
23. Gortzak-Uzan, L., Ignatchenko, A., Evangelou, A. I., Agochiya, M., Brown, K. A., St Onge, P., Kireeva, I., Schmitt-Ulms, G., Brown, T. J., Murphy, J., Rosen, B., Shaw, P., Jurisica, I., and Kislinger, T. (2008) A proteome resource of ovarian cancer ascites: integrated proteomic and bioinformatic analyses to identify putative biomarkers. J. Proteome Res. 7, 339-351
24. Sodek, K. L., Evangelou, A. I., Ignatchenko, A., Agochiya, M., Brown, T. J., Ringuette, M. J., Jurisica, I., and Kislinger, T. (2008) Identification of pathways associated with invasive behavior by ovarian cancer cells using multidimensional protein identification technology (MudPIT). Mol. Biosyst. 4, 762-773
25. Fermin, D., Basrur, V., Yocum, A. K., and Nesvizhskii, A. I. (2011) Abacus: a computational tool for extracting and pre-processing spectral count data for label-free quantitative proteomic analysis. Proteomics 11, 1340-1345
26. Dennis, G., Jr., Sherman, B. T., Hosack, D. A., Yang, J., Gao, W., Lane, H. C., and Lempicki, R. A. (2003) DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 4, P3
27. Slebos, R. J., Jehmlich, N., Brown, B., Yin, Z., Chung, C. H., Yarbrough, W. G., and Liebler, D. C. (2013) Proteomic analysis of oropharyngeal carcinomas reveals novel HPV-associated biological pathways. Int. J. Cancer 132, 568-579
28. Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., Antipin, Y., Reva, B., Goldberg, A. P., Sander, C., and Schultz, N. (2012) The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2, 401-404
29. Gao, J., Aksoy, B. A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S. O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E., Cerami, E., Sander, C., and Schultz, N. (2013) Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal. 6, pl1
30. Cancer Genome Atlas (2014) Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 507, 315-322
31. Li, B., and Dewey, C. N. (2011) RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics 12, 323
32. Cancer Genome Atlas (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455, 1061-1068
33. Benjamini, Y., and Hochberg, Y. (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 57, 289-300
34. Ren, B., Cam, H., Takahashi, Y., Volkert, T., Terragni, J., Young, R. A., and Dynlacht, B. D. (2002) E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. Genes Dev. 16, 245-256
35. Eke, I., Deuse, Y., Hehlgans, S., Gurtner, K., Krause, M., Baumann, M., Shevchenko, A., Sandfort, V., and Cordes, N. (2012) beta(1)Integrin/FAK/cortactin signaling is essential for human head and neck cancer resistance to radiotherapy. J. Clin. Invest. 122, 1529-1540
36. Eferl, R., and Wagner, E. F. (2003) AP-1: a double-edged sword in tumorigenesis. Nat. Rev. Cancer 3, 859-868
37. Dumitru, C. A., Bankfalvi, A., Gu, X., Eberhardt, W. E., Zeidler, R., Lang, S., and Brandau, S. (2013) Neutrophils activate tumoral CORTACTIN to enhance progression of orohypopharynx carcinoma. Front. Immunol. 4, 1-11
38. Nguyen, C. L., and Munger, K. (2009) Human papillomavirus E7 protein deregulates mitosis via an association with nuclear mitotic apparatus protein 1. J. Virol. 83, 1700-1707
39. Lechner, M., Frampton, G. M., Fenton, T., Feber, A., Palmer, G., Jay, A., Pillay, N., Forster, M., Cronin, M. T., Lipson, D., Miller, V. A., Brennan, T. A., Henderson, S., Vaz, F., O'Flynn, P., Kalavrezos, N., Yelensky, R., Beck, S., Stephens, P. J., and Boshoff, C. (2013) Targeted next-generation sequencing of head and neck squamous cell carcinoma identifies novel genetic alterations in HPV+ and HPV- tumors. Genome Med. 5, 49
40. Ward, M. J., Thirdborough, S. M., Mellows, T., Riley, C., Harris, S., Suchak, K., Webb, A., Hampton, C., Patel, N. N., Randall, C. J., Cox, H. J., Jogai, S., Primrose, J., Piper, K., Ottensmeier, C. H., King, E. V., and Thomas, G. J. (2013) Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer. Br. J. Cancer 110, 489-500
41. Kimple, R. J., Smith, M. A., Blitzer, G. C., Torres, A. D., Martin, J. A., Yang, R. Z., Peet, C. R., Lorenz, L. D., Nickel, K. P., Klingelhutz, A. J., Lambert, P. F., and Harari, P. M. (2013) Enhanced radiation sensitivity in HPV-positive head and neck cancer. Cancer Res. 73, 4791-4800
42. Andersen, A. S., Koldjaer Solling, A. S., Ovesen, T., and Rusan, M. (2013) The interplay between HPV and host immunity in head and neck squamous cell carcinoma. Int. J. Cancer 134, 2755-2763
43. Guerrera, I. C., Quetier, I., Fetouchi, R., Moreau, F., Vauloup-Fellous, C., Lekbaby, B., Rousselot, C., Chhuon, C., Edelman, A., Lefevre, M., Nicolas, J. C., Kremsdorf, D., Lacau Saint Guily, J., and Soussan, P. (2014) Regulation of interleukin-6 in head and neck squamous cell carcinoma is related to papillomavirus infection. J. Proteome Res. 13, 1002-1011
44. Rodrigo, J. P., Garcia-Carracedo, D., Garcia, L. A., Menendez, S., Allonca, E., Gonzalez, M. V., Fresno, M. F., Suarez, C., and Garcia-Pedrero, J. M. (2009) Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas. J. Pathol. 217, 516-523
45. Clark, E. S., Brown, B., Whigham, A. S., Kochaishvili, A., Yarbrough, W. G., and Weaver, A. M. (2009) Aggressiveness of HNSCC tumors depends on expression levels of cortactin, a gene in the 11q13 amplicon. Oncogene 28, 431-444
46. Jung, A. C., Briolat, J., Millon, R., de Reynies, A., Rickman, D., Thomas, E., Abecassis, J., Clavel, C., and Wasylyk, B. (2010) Biological and clinical relevance of transcriptionally active human papillomavirus (HPV) infection in oropharynx squamous cell carcinoma. Int. J. Cancer 126, 1882-1894
47. Okada, M., Nada, S., Yamanashi, Y., Yamamoto, T., and Nakagawa, H. (1991) CSK: a protein-tyrosine kinase involved in regulation of src family kinases. J. Biol. Chem. 266, 24249-24252
48. Bertino, J. R., Waud, W. R., Parker, W. B., and Lubin, M. (2011) Targeting tumors that lack methylthioadenosine phosphorylase (MTAP) activity: current strategies. Cancer Biol. Ther. 11, 627-632
49. Zhang, H., Chen, Z. H., and Savarese, T. M. (1996) Codeletion of the genes for p16INK4, methylthioadenosine phosphorylase, interferon-alpha1, in-terferon-beta1, and other 9p21 markers in human malignant cell lines. Cancer Genet. Cytogenet. 86, 22-28
50. Lubin, M., and Lubin, A. (2009) Selective killing of tumors deficient in methylthioadenosine phosphorylase: a novel strategy. PLoS One 4, e5735
51. Zuo, Z., Khattri, A., Keck, M. K., Cohen, E. E. W., Lingen, M. W., Vokes, E. E., and Seiwert, T. Y. (2014) Validation of two biologically distinct HPV-associated head and neck cancer subtypes and correlation with E5 expression. J. Clin. Oncol. 32 32:5s, 2014 (suppl; abstr 6031)
52. MacGrath, S. M., and Koleske, A. J. (2012) Cortactin in cell migration and cancer at a glance. J. Cell Sci. 125, 1621-1626